000 | 01909 a2200505 4500 | ||
---|---|---|---|
005 | 20250516182451.0 | ||
264 | 0 | _c20140717 | |
008 | 201407s 0 0 eng d | ||
022 | _a1476-4598 | ||
024 | 7 |
_a10.1186/1476-4598-12-147 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaraswati, Sarita | |
245 | 0 | 0 |
_aα-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway. _h[electronic resource] |
260 |
_bMolecular cancer _cNov 2013 |
||
300 |
_a147 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Retracted Publication | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHuman Umbilical Vein Endothelial Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 | _aMolecular Docking Simulation |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
650 | 0 | 4 | _aPolycyclic Sesquiterpenes |
650 | 0 | 4 |
_aProstate _xmetabolism |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xgenetics |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSesquiterpenes _xpharmacology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aKumar, Shakti | |
700 | 1 | _aAlhaider, Abdulqader A | |
773 | 0 |
_tMolecular cancer _gvol. 12 _gp. 147 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1476-4598-12-147 _zAvailable from publisher's website |
999 |
_c23294137 _d23294137 |